CMC Success Factors for Emerging Biotechs
Panel discussion summary
Join leaders from biotech, pharma, and CDMOs as they explore key CMC success factors across modalities — from small molecules to oligonucleotides, biologics, LNPs, and advanced delivery systems. This discussion will offer practical insights, share challenges, and highlight strategies to help biotechs scale, streamline, and accelerate development with technical and operational excellence.
Date, time and room information
May 5, 17:30-18:15, room Rio
Moderation
| Name | Position | Institution |
|---|---|---|
| Sonja Merkas | Founder, Creator & Doer | Livinovea GmbH |
Panelists
| Name | Position | Institution |
|---|---|---|
| Ed Yaworski | CTO | Genevant Sciences GmbH |
| Gabriella Rolli | CTO | TenPoint Therapeutics AG |
| Ivan Pogorelic | Head of CMC | Nxera Pharma AG |
| Michaela Freiberger | VP Oligo Manufacturing | Bachem AG |
Livinovea GmbH
Livinovea is a consultancy and service provider supporting pharma, biotech, startups, and CDMOs with a holistic, hands-on approach. We align business, technical, and operational aspects in every project to drive strategic growth, strengthen market positioning, manage internal & external initiatives, optimize processes, reduce costs, implement Lean, apply project management and solve complex challenges across the value chain. Our actions are shaping your success!
Host and event manager:
Logistics and marketing partner:
